Involvement of Src tyrosine kinase in Escherichia coli invasion of human brain microvascular endothelial cells  by Liu, Wei et al.
FEBS Letters 584 (2010) 27–32journal homepage: www.FEBSLetters .orgInvolvement of Src tyrosine kinase in Escherichia coli invasion of human brain
microvascular endothelial cells
Wei Liu 1, Wei-Dong Zhao 1, Jin-Chun Yan, Zhi-Yuan Ren, Wen-Gang Fang, Li Zhu,
De-Shu Shang, Yu-Hua Chen *
Department of Developmental Biology, Key Laboratory of Cell Biology, Ministry of Public Health, 92 Beier Road, Heping Distric, Shenyang 110001, China
Key Laboratory of Medical Cell Biology, Ministry of Education, China Medical University, 92 Beier Road, Heping Distric, Shenyang 110001, Chinaa r t i c l e i n f o
Article history:
Received 6 September 2009
Revised 24 October 2009
Accepted 30 October 2009
Available online 11 November 2009
Edited by Renee Tsolis
Keywords:
Src
Escherichia coli K1
Human brain microvascular endothelial cell
Phosphatidylinositol 3-kinase
Blood–brain barrier0014-5793/$36.00 Crown Copyright  2009 Publishe
doi:10.1016/j.febslet.2009.10.090
* Corresponding author. Address: Department of
Laboratory of Cell Biology, Ministry of Public Health, 9
Shenyang 110001, China. Fax: +86 24 2326 0246.
E-mail address: yhchen@mail.cmu.edu.cn (Y.-H. Ch
1 These authors contributed equally to this work.a b s t r a c t
Invasion of brain microvascular endothelial cells is a prerequisite for successful crossing of the
blood–brain barrier by Escherichia coli (E. coli), but the underlying mechanism remains unclear.
Here we showed activation of Src tyrosine kinase in E. coli K1 invasion of human brain microvascu-
lar endothelial cells (HBMEC). E. coli invasion of HBMEC and the E. coli-induced rearrangement of
actin ﬁlaments were blocked by Src inhibitors. Overexpression of dominant-negative Src in HBMEC
signiﬁcantly attenuated E. coli invasion and the concomitant actin ﬁlaments rearrangement. Fur-
thermore, E. coli K1-triggered phosphatidylinositol 3-kinase (PI3K) activation in HBMEC was effec-
tively blocked by Src inhibitors and dominant-negative Src. These results demonstrated the
involvement of Src and its interaction with PI3K in E. coli K1 invasion of HBMEC.
Structured summary:
MINT-7296127, MINT-7296136: Src (uniprotkb:P12931) physically interacts (MI:0915) with p85 (uni-
protkb:P27986) by anti bait coimmunoprecipitation (MI:0006)
MINT-7296149: F-actin (uniprotkb:P60709) and Src-DN (uniprotkb:P12931) colocalize (MI:0403) by ﬂuo-
rescence microscopy (MI:0416)
Crown Copyright  2009 Published by Elsevier B.V. on behalf of Federation of European Biochemical
society. All rights reserved.1. Introduction
Escherichia coli (E. coli) is the most common Gram-negative
organism causing meningitis during the neonatal period [1].
Despite great advances in antimicrobial chemotherapy and sup-
portive care, bacterial meningitis remains an important cause of
mortality and morbidity [1,2]. A better understanding of the
pathogenesis of this disease may contribute to clinical
intervention.
E. coli strains with the K1 capsular polysaccharide are the
predominant isolates (about 80%) from neonatal E. coli meningi-
tis [3,4]. Most cases of E. coli meningitis develop as a result of
hematogenous spread [5]. Entry of circulating E. coli into the
central nervous system requires passage across the blood–brain
barrier, which is mainly composed of brain microvascular endo-d by Elsevier B.V. on behalf of Fede
Developmental Biology, Key
2 Beier Road, Heping Distric,
en).thelial cells (BMEC) [6]. Invasion of BMEC is a crucial event in
the pathogenesis of E. coli meningitis. Several genetic determi-
nants contributing to bacterial invasion of BMEC have been iden-
tiﬁed in E. coli K1, such as cnf1, ﬁmH, OmpA, ibeA, and ibeB [7]. In
human brain microvascular endothelial cells (HBMEC), evidences
showed that reorganization of the actin cytoskeleton and intra-
cellular signaling are involved in E. coli K1 invasion of HBMEC
[7].
Src is a member of a larger family of related tyrosine kinases
that includes Fyn, Yes, Lck, Blk, Lyn, Hck, Yrk and Fgr. Src signal-
ing has been implicated in a variety of cellular processes, includ-
ing cell growth, survival and motility [8,9]. The involvement of
Src was found in Staphylococcus aureus invasion of embryonic kid-
ney cells, Shigella invasion of epithelial cells and uropathogenic
E. coli invasion of bladder epithelial cells [10–12]. Src has been
shown to act upstream of phosphatidylinositol 3-kinase (PI3K)
in cell transformation, proliferation and survival [13–15]. PI3K
has been proved for E. coli invasion of HBMEC [7,16]. These
prompt us to examine whether Src tyrosine kinase is associated
with E. coli K1 invasion of HBMEC. In this paper, we showed
the activation of Src in E. coli K1 invasion of HBMEC andration of European Biochemical society. All rights reserved.
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signaling in this process.
2. Materials and methods
2.1. Bacterial strains and media
E. coli RS218 (O18: K1: H7) is a clinical isolate from the cerebro-
spinal ﬂuid of a newborn infant with meningitis [17], and E44 is a
spontaneous rifampin-resistant mutant of RS218. E44 was grown
at 37 C in brain-heart infusion (BD Biosciences, Sparks, MD,
USA) with rifampin (100 lg/ml).
2.2. Cell culture
HBMEC was a generous gift from Dr. K.S. Kim (Johns Hopkins
University, Baltimore, MD). They were cultured in RPMI 1640 med-
ium, supplemented with 10% fetal bovine serum (Hyclone, Logan,
UT, USA), 10% Nu-serum (BD Biosciences, Bedford, MA, USA),
2 mM glutamine, 1 mM sodium pyruvate, 1  non-essential amino
acid and 1 MEM vitamin. Cells were incubated at 37 C in a 5%
CO2, 95% air humidiﬁed atmosphere.
2.3. Plasmids and transfection
The mouse Src with K296R and Y528F mutations cloned into
pEGFP-N1 (Src-DN) [18] was a generous gift from Dr. Chris Taylor
(Georgetown University). HBMEC was transfected with the plas-
mids using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA)
according to the manufacture’s instruction. Brieﬂy, 4 lg of plasmid
in 250 ll of RPMI 1640 were mixed with10 ll Lipofectamine 2000
in 250 ll of RPMI 1640. The mixture was then added to the wells
containing HBMEC. The cells were exposed to the transfection mix-
ture for 4 h at 37 C. After the transfection,the cells were selected
in the presence of G418 (300 lg/ml; Invitrogen). Resistant colonies
were selected and conﬁrmed by Western blot. Stable HBMEC cell
line transfected with dominant-negative PI3K (p110c D948–981)
was constructed previously [19].
2.4. Bacterial invasion and adhesion assays
Invasion of HBMEC by E. coli K1 were performed as described
previously [17,20]. Brieﬂy, bacteria (107 CFU/well) were added to
conﬂuent monolayers of HBMEC in 24-well plates at a multiplicity
of infection of 100. The monolayers were incubated at 37 C for
1.5 h to allow invasion to occur. The number of intracellular bacte-
ria was determined after the extracellular bacteria were killed by
incubation of the monolayers with experimental medium (RPMI
1640, 5% fetal bovine serum and 1 mM sodium pyruvate) contain-
ing gentamicin (100 lg/ml) for 1 h at 37 C. Then the monolayers
were washed and lysed with 0.5% Triton X-100. The released intra-
cellular bacteria were enumerated by plating on LB agar plates. For
inhibition studies, HBMEC were incubated with PP1 (Biomol, Plym-
outh Meeting, PA, USA), PP2 and PP3 (Calbiochem, San Diego, CA,
USA) for 30 min before adding of bacteria, with HBMEC treated
with vehicle (DMSO) as a control. Bacterial adhesion assay to
determine the number of total cell-associated bacteria was done
as described above except that the gentamicin step was omitted.
2.5. Western blot
Cells were washed and prepared with RIPA buffer (50 mM
Tris–HCl, 150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.1% so-
dium dodecylsulfate) containing protease inhibitor cocktail
(Roche, Indianapolis, IN, USA). The samples were separated by
SDS–PAGE, and then transferred to PVDF membrane (Millipore,Bedford, MA, USA). The membrane was blocked with 5% non-fat
milk and incubated with the ﬁrst antibody at 4 C overnight. Then
the blots were incubated with HRP-conjugated secondary anti-
body and the immunoreactive bands were visualized by SuperSig-
nal West Pico Chemiluminescent Substrate (Pierce, Rockford, IL,
USA). The antibodies against Akt and phosphorylated Ser473 of
Akt (p-Akt) were from Santa Cruz Biotech, Santa Cruz, CA, USA.
Src antibody was from Abcam, Cambridge, UK. The antibody that
recognizes phosphorylated Tyr416 of Src (p-Src) was from Cell
Signaling Technology, Beverly, MA, USA. Antibody recognizes
the p85 subunit of PI3K was from Upstate, Temecula, CA, USA.
When indicated, the HBMEC was treated with PI3K inhibitors
LY294002 and Wortmannin (Calbiochem, La Jolla, CA, USA). For
quantitative analysis, the mean density of each band was mea-
sured with Multi Gauge V3.1 software, and the band density of
activated form of the protein was divided by the density of the
corresponding total protein band to obtain the normalized band
density.
2.6. Immunoprecipitation
Cells were washed and lysed with Lysis buffer (50 mM Tris,
150 mM NaCl, 2 mM EDTA, 2 mM EGTA, 1% Triton X-100, 1 mM so-
dium orthovanadate, 25 mM b-glycerophosphate, 1 mM phenyl-
methylsulfonyl ﬂuoride) containing protease inhibitor cocktail.
The cell lysates were centrifuged and the supernatant was col-
lected. The protein content was determined by Bradford method.
1 mg of protein was incubated with appropriate antibody over-
night at 4 C and incubated for 2 h with Protein A/G-agarose (Santa
Cruz Biotech). The proteins from immune complexes were eluted
in SDS sample buffer for Western blot analysis.
2.7. Immunoﬂuorescence
HBMEC grown on coverslips was incubated with E. coli E44 for
30 min at 37 C. The cells were washed and ﬁxed with 4% parafor-
maldehyde. Subsequently, the cells were permeabilized with 0.2%
Triton X-100 in PBS and then blocked with 5% BSA in PBS. TRITC-la-
beled phalloidin (Sigma–Aldrich, St. Louis, MO, USA) was used to
stain the actin ﬁlaments. The cells were washed again and the cov-
erslips were mounted and analyzed using immunoﬂuorescence
microscope (Olympus BX51, Tokyo, Japan). When indicated, the
HBMEC was incubated with 10 lM of PP1, PP2 or PP3 before the
bacterial infection.
3. Results
3.1. Inhibition of E. coli K1 invasion by Src inhibitors
Src is a non-receptor protein tyrosine kinase, the expression and
activation of which is found in kinds of mammalian cells including
HBMEC [9,21]. In an attempt to examine whether Src kinase is in-
volved in E. coli K1 invasion of HBMEC, bacterial invasion and adhe-
sion assayswere performed in the presence of kinase inhibitors. PP1
and PP2, which has been identiﬁed as Src-speciﬁc inhibitors [22],
were used to inhibit the activity of Src in HBMEC. PP3 [10], an inac-
tive analog of both PP1 and PP2, was used as a negative control. As
shown in Fig. 1A, either PP1 or PP2 treatment signiﬁcantly inhibited
the ability of E. coli E44 to invade HBMEC. PP1 inhibitor could block
E. coli invasion of HBMEC in a dose-dependent manner with a 71.4%
inhibition at 20 lM. Similarly, PP2 could block E. coli invasion in a
dose-dependent manner with a 61.4% inhibition at 20 lM. In con-
trast, PP3 did not have any effect. However, these compounds,
including PP1, PP2 and PP3, did not interfere with E. coli adhesion
on HBMEC (Fig. 1B). These results indicate that Src tyrosine kinase
may be associated with E. coli K1 invasion of HBMEC.
Fig. 1. Src inhibitors block E. coli K1 invasion of HBMEC. Conﬂuent HBMECmonolayers on the 24-well plate were treated with the indicated concentrations of PP1, PP2, or PP3
for 30 min before addition of the bacteria, and then the invasion (A) and adhesion assay (B) were conducted as described in Section 2. Results are presented as relative percent
invasion or adhesion of the parent E. coli K1 strain E44, which is deﬁned as 100%. Values are means ± S.D. of ﬁve independent experiments done in triplicate. **P < 0.01.
Fig. 2. Activation of Src in HBMEC stimulated with E. coli K1. Conﬂuent monolayers of HBMECwere infected with E. coli E44 for indicated periods of time. The cell lysates were
prepared, separated by SDS-PAGE, and immunoblotted with either p-Src or Src antibody as described in Section 2 (A). HBMEC monolayers were treated with 10 lM of PP1,
PP2 or PP3 for 30 min and then infected with E44 for 15 min, and the level of Src phosphorylation in HBMEC was analyzed by Western blot (n = 3) (B). *P < 0.05.
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The chief phosphorylation sites of Src include Tyr416 that re-
sults from autophosphorylation and Tyr527 that results from phos-
phorylation by C-terminal Src kinase [8]. Previous studies revealed
that the phosphorylation of Tyr416 was a key event to achieve
maximal Src kinase activity [23]. As shown in Fig. 2A, Tyr416 phos-
phorylation of Src in HBMEC is increased following stimulation
with E. coli E44 with maximum phosphorylation at 15 min. The
E. coli-induced Src phosphorylation in HBMEC was abolished by
both PP1 and PP2 (Fig. 2B), while the increased Src phosphoryla-
tion was not changed by PP3 treatment. These results indicate that
Src tyrosine kinase is activated in HBMEC stimulated by E. coli K1.
3.3. Dominant-negative mutant of Src blocked E. coli K1 invasion
of HBMEC
It has been shown that the combined mutations in the ATP
binding site (K296M) and the regulatory C-terminal tyrosine resi-
due (Y528F) lead to a Src dominant-negative mutant (K296M/
Y528F) with an open conformation in which SH2 and SH3 domains
may interact with other proteins but devoid of enzymatic activity
[24]. To further investigate the role of Src in E. coli K1 invasion,
dominant-negative mutant of Src was stably transfected into
HBMEC. The expression of dominant-negative form of Src protein
was veriﬁed (Fig. 3A). The phosphorylation of Src induced by
E. coli was signiﬁcantly decreased in HBMEC transfected with
dominant-negative Src (Src-DN) compared to the vector control
(Fig. 3B). Bacterial invasion and adhesion assays showed thatSrc-DN signiﬁcantly reduced the ability of E. coli K1 to invade
HBMEC (Fig. 3C), but did not interfere with E. coli adhesion on
HBMEC (Fig. 3D). Taken together, these results demonstrate that
Src kinase activation in HBMEC is required for E. coli K1 invasion.
3.4. E. coli K1-induced actin cytoskeleton rearrangement is associated
with Src activation in HBMEC
Evidences showed that E. coli K1 invasion of HBMEC required
actin cytoskeleton rearrangement [7]. In order to further evaluate
the role of Src in E. coli K1 invasion of HBMEC, HBMEC were treated
with Src inhibitors, and the actin cytoskeleton was stained with
TRITC-phalloidin. As shown in Fig. 4A, the normal HBMEC exhib-
ited prominent stress ﬁbers crossing the cytoplasm. When the
HBMEC was challenged with E44, the stress ﬁbers almost disap-
peared and the actin ﬁlaments were accumulated at the cell bor-
der. Src inhibitors, PP1 and PP2, markedly blocked E. coli-induced
actin cytoskeleton rearrangement, whereas PP3 had no effect.
Moreover, E44 fails to induce actin changes in HBMEC transfected
with Src-DN (Fig. 4B). These data demonstrate that Src is involved
in E. coli-induced actin cytoskeleton rearrangement in HBMEC,
which is necessary for the E. coli invasion of HBMEC.
3.5. Src is an upstream signal molecule of PI3K for E. coli K1 invasion
of HBMEC
PI3K plays an important role in the process of pathogen inva-
sion into host cells, including E. coli K1 invasion into HBMEC [7].
Here, we explored the relationship between Src kinase and PI3K
Fig. 3. Overexpression of dominant-negative Src in HBMEC abolished E. coli K1 invasion. HBMEC were transfected with Src-DN or with empty vector pEGFP-N1, and the
expression of dominant-negative form of Src was detected by Western blot with anti-GFP antibody. For loading control, GAPDH in each sample was immunoblotted (A).
Conﬂuent monolayers of HBMEC transfected with Src-DN or pEGFP-N1 were infected with E. coli E44 for indicated periods of time, and the level of Src phosphorylation in
HBMEC was analyzed by Western blot (n = 3) (B). HBMEC transfected with Src-DN or pEGFP-N1 was subjected to bacterial invasion (C) and adhesion assay (D). Values are
means ± S.D. of three independent experiments done in triplicate. *P < 0.05, **P < 0.01.
Fig. 4. E. coli K1-induced actin cytoskeleton rearrangement in HBMEC is associated with Src tyrosine kinase. HBMEC cultured on coverslips were treated with 10 lM of PP1,
PP2 or PP3 for 30 min, then the cells were incubated with E44 for 30 min and immunoﬂuorescence was done to stain the actin ﬁlaments in HBMEC (A). HBMEC transfected
with Src-DN or pEGFP-N1 (vector) were incubated with E44 for 30 min, and the GFP and actin ﬁlaments were analyzed by immunoﬂuorescence microscopy (B). Scale
bar = 20 lm.
30 W. Liu et al. / FEBS Letters 584 (2010) 27–32in HBMEC stimulated with E. coli K1. The phosphorylation state of
Akt was used to check the activation of PI3K [16,19]. As shown in
Fig. 5A, treatment with PP1 or PP2 signiﬁcantly decreased the
phosphorylation of Akt in HBMEC challenged with E44; however,
treatment with LY294002 or Wortmannin had no effect on the
phosphorylation level of Src (Fig. 5B). Furthermore, the E. coli-in-
duced Akt phosphorylation in HBMEC was blocked by Src-DN
transfection (Fig. 5C). Transfection of dominant-negative PI3K(Dp110) into HBMEC had no effect on the E. coli-induced Src
phosphorylation, although the E. coli-induced Akt phosphorylation
in HBMEC was inhibited by Dp110 (Fig. 5D and E). These results
suggest that Src, act as an upstream signal molecule of PI3K, con-
tributes to E. coli K1 invasion of HBMEC.
PI3K is a heterodimer consisting of a regulatory subunit (p85)
and a catalytic subunit (p110). p85 contains an SH3 domain and
two SH2 domains that interact with various intracellular signaling
Fig. 5. Src is an upstream signal molecule of PI3K in E. coli K1 invasion of HBMEC. Conﬂuent HBMEC were treated with 10 lM of PP1, PP2 or PP3 for 30 min, and then
incubated with E. coli E44 for 15 min. Akt phosphorylation in HBMEC was detected by Western blot (A). Conﬂuent HBMEC were treated with LY294002 (10 lM) or
Wortmannin (100 nM) for 30 min, and then incubated with E44 for indicated times, and Src phosphorylation in HBMEC was analyzed (B). HBMEC transfected with Src-DN or
pEGFP-N1 were incubated with E44 for indicated periods of time, and Akt phosphorylation in the cells was analyzed by Western blot (C). Conﬂuent monolayers of HBMEC
transfected with dominant-negative PI3K (Dp110) or control vector pcDNA3.1-myc-his-A were incubated with E44 for indicated periods of time, and phosphorylated Akt (D)
and Src (E) in the cells was examined. *P < 0.05.
Fig. 6. Src interaction with PI3K in HBMEC infected with E. coli K1. Cell lysates of
HBMEC stimulated with E44 were prepared at the indicated time and 1 mg total
proteins were immunoprecipitated (IP) with anti-Src antibody (A) or anti-p85
antibody (B), and the precipitated proteins were analyzed by Western blot (WB)
using anti-p85 and anti-Src antibody. *P < 0.05.
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PI3K and Src has been demonstrated in several works [9]. Here,
immunoprecipitation assay was carried out to examine the inter-
action between Src and p85 in HBMEC challenged with E. coli E44.
As shown in Fig. 6, the interaction of Src with p85 in HBMEC
stimulated with E44 reached a peak at 15 min, which was consis-
tent with the time of E44-induced Src activation. This suggests
that the association of Src with p85 subunit of PI3K maybe in-
volved in the activation of PI3K, leading to E. coli K1 invasion of
HBMEC.4. Discussion
E. coli K1, the most common Gram-negative bacterium that
causes meningitis in neonates, invades HBMEC by rearranging
host cell actin cytoskeleton [7]. Actin ﬁlament reorganization by
E. coli K1 requires activation of intracellular signaling; however,
the underlying mechanism remains obscure. Some studies
showed that E. coli K1 invasion involves activation of the intracel-
lular molecules including PI3K, focal adhesion kinase (FAK), Rho
GTPases, phospholipase (PLC)-gamma 1, protein kinase C (PKC)-al-
pha, and signal transducer and activator of transcription 3 (Stat3)
in HBMEC [7,26–28]. In this study, we found activation of Src
tyrosine kinase in HBMEC stimulated with E. coli K1 and demon-
strated that Src is required for the activation of PI3K/Akt signaling
in this process.
Activation of Src in host cells has been implicated in the process
of pathogen invasion, including Staphylococcus aureus, Shigella and
uropathogenic E. coli [10–12]. In this study, our results showed that
Src inhibitors, PP1 and PP2, blocked E. coli K1 invasion of HBMEC. It
is known that Src activation is mainly regulated by phosphoryla-
tion at the tyrosine 416 residue [23]. Our further results showed
that Tyr416 phosphorylation of Src increased signiﬁcantly in
HBMEC stimulated with E. coli K1, and this increased phosphoryla-
tion was abolished by PP1 and PP2, a concentration at which E. coli
K1 invasion was effectively inhibited. Importantly, we found that
overexpression of the dominant-negative mutant of Src in HBMEC
blocked E. coli K1 invasion of HBMEC and the concomitant
32 W. Liu et al. / FEBS Letters 584 (2010) 27–32rearrangement of actin ﬁlaments. These ﬁndings demonstrate that
Src is required for E. coli K1 invasion of HBMEC. This conclusion
was also supported by the E. coli K1-induced Src interaction with
PI3K in HBMEC (Figs. 5 and 6). Earlier report showed that PP1
did not interfere with E. coli K1 invasion of HBMEC [29]. This dis-
crepancy could be due to the method of PP1 treatment, that is,
the inhibitory effect of PP1 could be observed when it was present
throughout the process of bacterial invasion. However, routine pre-
treatment of HBMEC by PP2 inhibited E. coli K1 invasion effectively,
which suggested the different characteristics between these two
inhibitors. Similar discrepancy was reported in the uropathogenic
E. coli invasion of bladder epithelial cells [10,30].
We have previously indentiﬁed that PI3K/Akt signaling resulted
in activation of coﬁlin, which promoted reorganization of actin
cytoskeleton for E. coli K1 entry into HBMEC [31]. Direct interaction
of the p85 subunit of PI3K with the SH2 and SH3 domains of Src
has been demonstrated [9]. In this study, our results showed that
Src- PI3K complex is increased in HBMEC stimulated with E. coli
K1 (Fig. 6). We also found that overexpression of dominant-nega-
tive mutant of PI3K in HBMEC and treatment of HBMEC with
PI3K inhibitors had no effect on the E. coli K1-induced Src activa-
tion, whereas overexpression of dominant-negative Src in HBMEC
and treatment of HBMEC with Src inhibitors abolished the activa-
tion of PI3K stimulated by E. coli K1. These results indicated that
Src is an upstream signal molecule of PI3K in HBMEC for E. coli
K1 invasion.
Amongst intracellular signaling molecules activated by E. coli
K1, FAK [16] and Stat3 [28] have been shown to act upstream of
PI3K in E. coli K1 invasion of HBMEC. Further studies are needed
to elucidate the relationship between these signaling molecules
and Src tyrosine kinase contributing to E. coli K1 invasion of
HBMEC. Also, it is interesting to explore the relationship between
Src and the other members of Src family, such as Lyn, Fyn, Yes,
Lck, Blk, Hck, during the process of E. coli K1 invasion of HBMEC
in the future.
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